Specifically, MG modifies the transcriptional coactivator p300 and reduces its ability to bind to HIF-1α, thus limiting the function of HIF-1α to promote angiogenesis under hypoxic conditions and inhibiting nutrient supply to the tumor (118). Here, HIF1A is linked to neoplasm.